Login / Signup

Influence of sex on the persistence of different classes of targeted therapies for psoriatic arthritis: a cohort study of 14 778 patients from the French health insurance database (SNDS).

Laura Pina VegasLaetitia PensoEmilie SbidianPascal Claudepierre
Published in: RMD open (2023)
The treatment persistence was lower for women than men for TNFi and IL17i but not for IL12/23i, IL23i or JAKi.
Keyphrases
  • health insurance
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • polycystic ovary syndrome
  • prognostic factors
  • metabolic syndrome
  • patient reported outcomes
  • middle aged
  • insulin resistance